Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
Metastasis-the spread of tumour cells from a primary lesion to distant organs-is the main cause of cancer-related death, and bone marrow (BM) is a frequent site for the settlement of disseminated tumour cells. Many BM samples harbour isolated tumour cells, whereas tumour cell clusters, as the potential precursors of solid distant metastases, are rarely detected after current enrichment procedures. We have analysed BM samples from 43 patients with carcinomas of the breast, colon and ovaries; 41 of these patients had no clinical signs of overt metastases (stage M0). Tumour cells in BM were enriched with immunomagnetic beads coupled to monoclonal antibodies against both EpCAM and HER2/neu. After enrichment, tumour cells were identified by immunostaining with the anti-cytokeratin antibody A45-B/B3. In total, 886 CK-positive cells were detected in 16 (35%) samples after immunomagnetic enrichment as compared to 34 cells in 9 (21%) samples using Ficoll density centrifugation previously used as the standard enrichment technique. Most remarkably, clusters of 2 to 10 CK-positive cells were found in 75% of CK-positive samples enriched by immunobeads, whereas no CK-positive cell clusters were detected after Ficoll enrichment. The method described offers an excellent tool for the enrichment of micrometastatic tumour cell clusters; these clusters may represent the initial stage of development from a single disseminated tumour cell towards an overt metastasis.
Woelfle
Ute
U
Institute of Tumour Biology, Center of Experimental Medicine, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
Breit
Elisabeth
E
Zafrakas
Kristine
K
Otte
Marcus
M
Schubert
Falk
F
Müller
Volkmar
V
Izbicki
Jakob R
JR
Löning
Thomas
T
Pantel
Klaus
K
D019046:Bone Marrow Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000556:secondary*; D001943:Breast Neoplasms; D002469:Cell Separation / Q000379:methods; D002499:Centrifugation, Density Gradient; D003110:Colonic Neoplasms; D005260:Female; D005362:Ficoll; D006801:Humans; D007150:Immunohistochemistry; D018189:Immunomagnetic Separation / Q000379:methods*; D007633:Keratins / Q000378:metabolism; D008297:Male; D009362:Neoplasm Metastasis / Q000473:pathology*; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms
D005362:Ficoll; D007633:Keratins